Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 12Unspecified Adult Solid Tumor, Protocol Specific 3Breast Neoplasms 3Precancerous Conditions 2Lung Neoplasms 2Hypocalcemia 2Vitamin D Deficiency 1Tuberous Sclerosis 1Tobacco Use Disorder 1Thyroiditis 1Thyroid Nodule 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pinealoma 1Pancreatic Neoplasms 1Osteoporosis 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Medulloblastoma 1Leukemia 1Hyperthyroidism 1Hyperplasia 1Hyperparathyroidism 1Goiter 1

Interventions

Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Cisplatin 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adult Solid Neoplasm × Calcitriol × Clear all
NCT01093092 2016-01-12

Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery

Roswell Park Cancer Institute

Phase 1 Terminated
14 enrolled

Adult Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡